CHANRION; Maia

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHANRION; Maia.The latest application filed is for "3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents".

Company Profile

0.10.12

CHANRION; Maia - Issy les Moulineaux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3,6-diamino-pyridazin-3-yl Derivatives, Pharmaceutical Compositions Containing Them And Their Uses As Pro-apoptotic Agents App 20220289734 - DAVIDSON; James Edward Paul ; et al.	2022-09-15
Substituted piperidines as inhibitors of ubiquitin specific protease 7 Grant 11,332,472 - Kotschy , et al. May 17, 2	2022-05-17
Cyclodextrin-based Formulation Of A Bcl-2 Inhibitor App 20210353633 - CHEMIN; Caroline ; et al.	2021-11-18
Substituted piperidines for the treatment of cancer Grant 11,046,681 - Kotschy , et al. June 29, 2	2021-06-29
New Piperidinyl Derivatives As Inhibitors Of Ubiquitin Specific Protease 7 App 20200407363 - KOTSCHY; Andras ; et al.	2020-12-31
Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof Grant 10,765,680 - Porter , et al. Sep	2020-09-08
Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,711,010 - Szlavik , et al.	2020-07-14
(Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,654,849 - Kotschy , et al.	2020-05-19
Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,618,909 - Balint , et al.	2020-04-14
Combination Of A Mcl-1 Inhibitor And A Taxane Compound, Uses And Pharmaceutical Compositions Thereof App 20190336505 - PORTER; Dale ; et al.	2019-11-07
Ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,457,689 - Paczal , et al. Oc	2019-10-29
Bicyclic Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20190248805 - Balint; Balazs ; et al.	2019-08-15
Hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,322,131 - Szlavik , et al.	2019-06-18
Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,323,041 - Balint , et al.	2019-06-18
Hydroxyester Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20190161496 - SZL VIK; Zoltan ; et al.	2019-05-30
Piperidinyl Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20190144448 - KOTSCHY; Andras ; et al.	2019-05-16
(hetero)aryl-substituted-piperidinyl Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing The App 20190144449 - KOTSCHY; Andras ; et al.	2019-05-16
Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them Grant 10,227,358 - Szlavik , et al.	2019-03-12
Ammonium Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20190031677 - PACZAL; Attila ; et al.	2019-01-31
Bicyclic Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20180258098 - BALINT; Balazs ; et al.	2018-09-13
Hydroxyacid Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20180185369 - SZL VIK; Zoltan ; et al.	2018-07-05
Hydroxyester Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20180170947 - SZLAVIK; Zoltan ; et al.	2018-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.